Tevogen Inc. Warrant financials
$0.0601−7.54%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$5.7M | -$5.4M | -$4.6M | -$5.7M | -$5.4M | -$10.4M | -$1.9M | -$6.1M | -$8.6M | -$29.5M |
| Net income | -$5.8M | -$5.6M | -$5.2M | -$5.7M | -$5.5M | -$10.5M | -$6.0M | -$5.9M | -$9.7M | $10.5M |
| Net margin | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | $-1.52 | $-1.61 | — | $-1.50 | $-1.71 | $-3.25 | $-2.50 | $-1.50 | $-2.00 | $-13.00 |
| EBITDA | -$5.6M | -$5.4M | -$4.2M | -$5.7M | -$5.4M | -$10.3M | -$9.4M | -$6.0M | -$8.6M | -$29.4M |
| Operating cash flow | -$3.0M | -$2.7M | -$2.2M | -$3.6M | -$3.2M | -$3.3M | -$3.0M | -$3.8M | -$3.0M | -$2.2M |
| Free cash flow | -$3.0M | -$2.7M | -$2.2M | -$3.6M | -$3.2M | -$3.3M | -$3.0M | -$3.8M | -$3.0M | -$2.2M |
| Diluted shares | 3.8M | 3.5M | — | 3.9M | 3.3M | 3.2M | 2.4M | 3.4M | 3.1M | 2.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.1M | $692.3K | $552.4K | $1.0M | $685.2K | $2.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $8.1M | $8.1M | $6.1M | $6.1M | $6.1M | $4.7M |
| Total assets | $4.7M | $4.9M | $4.4M | $4.5M | $4.3M | $4.1M |
| Total liabilities | $13.6M | $14.8M | $12.6M | $12.3M | $13.8M | $11.8M |
| Shareholders' equity | -$8.9M | -$9.8M | -$8.2M | -$7.8M | -$9.5M | -$7.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology